| Literature DB >> 25058308 |
Eamonn P Culligan1, Roy D Sleator2, Julian R Marchesi3, Colin Hill1.
Abstract
The human gut microbiome consists of at least 3 million non-redundant genes, 150 times that of the core human genome. Herein, we report the identification and characterisation of a novel stress tolerance gene from the human gut metagenome. The locus, assigned brpA, encodes a membrane protein with homology to a brp/blh-family β-carotene monooxygenase. Cloning and heterologous expression of brpA in Escherichia coli confers a significant salt tolerance phenotype. Furthermore, when cultured in the presence of exogenous β-carotene, cell pellets adopt a red/orange pigmentation indicating the incorporation of carotenoids in the cell membrane.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25058308 PMCID: PMC4110020 DOI: 10.1371/journal.pone.0103318
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Bacterial strains and plasmids.
| Strain, plasmid or transposon | Genotype or characteristic(s) | Source or reference |
|
| ||
|
| F−
| Epicentre Biotechnologies, Madison, WI, USA |
| SMG 6 | EPI300 containing pCC1FOS fosmid with ∼34 kb of metagenomicDNA from human gut microbiome | This study |
| SMG 6-EZTn | Transposon insertion in gene 24 (which precedes acyltransferase gene | This study |
| SMG 6-EZTn | Transposon insertion in | This study |
| SMG 6-EZTn | Transposon insertion in acyltransferase gene ( | This study |
| SMG 6-EZTn | Transposon insertion in | This study |
|
| MC4100 |
|
|
| MKH13 containing empty pCI372 plasmid | This study |
|
| MKH13 containing pCI372 with | This study |
|
| MKH13 containing pCI372 with | This study |
|
| MKH13 containing pCI372 with | This study |
|
| EPI300 containing pBAD with | This study |
|
| MKH13 containing pCI372 with | This study |
|
| MKH13 containing pCI372 with | This study |
|
| EPI300 containing pBAD with | This study |
|
| EPI300 containing pBAD with | This study |
|
| EPI300 containing pBAD with | This study |
|
| ||
| pCI372 | Shuttle vector between |
|
| pCC1FOS | Fosmid cloning vector, CmR | Epicentre Biotechnologies, Madison, WI, USA |
| pBAD | L-arabinose inducible expression vector, AmpR | Invitrogen, USA |
|
| ||
| EZ-Tn | Hyperactive Tn | Epicentre Biotechnologies, Madison, WI, USA |
CmR, KanR and AmpR = chloramphenicol, kanamycin and ampicillin resistance respectively.
Figure 1Growth of metagenomic clones SMG 1, 6 and 52 compared to EPI300 carrying an empty fosmid vector (pCC1FOS) in (A) LB broth and (B) LB broth supplemented with 7% NaCl.
List of putative proteins encoded on SMG 6 fosmid insert.
| Gene # | Strand | Length (a.a) | BlastP top hit | Best hit organism (BlastP) | e-value | Query coverage | % ID (a.a) | % G+C |
| 1 | + | 418 | Hypothetical protein (BT_1366) |
| 0.00E+00 | 100% | 100% | 48.05 |
| 2 | – | 124 | Conserved hypothetical protein (DUF 3127) |
| 6.00E−67 | 100% | 100% | 52.00 |
| 3 | + | 374 | DNA polymerase III, chain beta (beta clamp superfamily) |
| 0.00E+00 | 100% | 100% | 47.64 |
| 4 | + | 255 | DNA polymerase III, epsilon chain (DDEHh exonuclease domain) |
| 4.00E−149 | 100% | 100% | 45.57 |
| 5 | + | 400 | Phosphopantothenoylcysteine decarboxylase (Flavoprotein, DFP domains) |
| 0.00E+00 | 100% | 99% | 49.38 |
| 6 | + | 555 | DNA repair protein, RecN (ABC_RecN domains) |
| 0.00E+00 | 100% | 99% | 50.66 |
| 7 | + | 247 | tRNA/rRNA methyltransferase (SpoU_sub_bind and methylase domains) |
| 5.00E−143 | 100% | 100% | 47.98 |
| 8 | + | 568 | Tetratricopeptide repeat family protein (Trypsin_2 and TPR domains) |
| 0.00E+00 | 100% | 99% | 46.34 |
| 9 | + | 190 | Putative transcriptional regulator (NGN_SP_UpxY domain; NusG) |
| 4.00E−135 | 100% | 99% | 42.76 |
| 10 | + | 122 | Transcriptional regulator (UpxZ domain) |
| 2.00E−63 | 100% | 97% | 42.82 |
| 11 | + | 789 | Capsule polysaccharide export protein (Poly_export and SLBB domains) |
| 0.00E+00 | 100% | 99% | 48.90 |
| 12 | + | 378 | Uncharacterised protein, putative chain-length determining |
| 0.00E+00 | 100% | 71% | 42.83 |
| 13 | + | 647 | Capsular polysaccharide biosynthesis protein (CapD) (UDP_invert_4–6DH_SDR_e domain) |
| 0.00E+00 | 98% | 87% | 44.24 |
| 14 | + | 410 | UDP-glucose dehydrogenase (NAD_Gly3P_dh_N and UDPG_MGDP_dh domains) |
| 0.00E+00 | 100% | 82% | 43.23 |
| 15 | + | 348 | NAD dependent epimerase/dehydratase (NADB_Rossmann superfamily) |
| 3.00E−176 | 100% | 84% | 42.50 |
| 16 | + | 189 | dTDP-4-dehydrorhamnose 3,5-epimerase (dTDP_sugar_isom domain) |
| 3.00E−124 | 100% | 90% | 43.33 |
| 17 | + | 451 | Alanine ABC transporter permease (DltB domain; MBOAT superfamily) |
| 2.00E−136 | 97% | 57% | 37.20 |
| 18 | + | 292 | Hypothetical protein Alfi_2997 (DUF 535 superfamily) |
| 1.00E−38 | 96% | 30% | 36.61 |
| 19 | + | 172 | Hypothetical protein BF638R_1544 (RimL domain) |
| 2.00E−67 | 99% | 68% | 39.35 |
| 20 | + | 368 | Putative LPS biosynthesis transmembrane protein |
| 4.00E−51 | 98% | 36% | 33.06 |
| 21 | + | 331 | Hypothetical protein BSHG_0833 |
| 2.00E−83 | 100% | 43% | 31.02 |
| 22 | + | 479 | Hypothetical protein, polysaccharide export (MATE_tuaB_like domain) |
| 6.00E−150 | 98% | 46% | 36.11 |
| 23 | + | 376 | Hypothetical protein HMPREF9447_00823 (AHBA_syn domain; AAT_I superfamily) |
| 0.00E+00 | 100% | 81% | 47.48 |
| 24 | + | 184 | Putative acetyltransferase (LbetaH_MAT_like domain) |
| 6.00E−57 | 94% | 55% | 40.00 |
| 25 | + | 98 | Hypothetical protein, putative acyltransferase |
| 7.00E−07 | 98% | 37% | 30.64 |
|
|
|
|
|
|
|
|
|
|
| 27 | + | 288 | Hypothetical protein HMPREF0994_06876 (ATP-grasp_tupA domain) |
| 2.00E−81 | 99% | 70% | 35.01 |
| 28 | + | 366 | Uncharacterised protein BN814_01473, putative glycosyltransferase (GT1_ams_like domain) |
| 1.00E−132 | 98% | 54% | 39.69 |
| 29 | + | 366 | Putative glycosyltransferase |
| 2.00E−53 | 98% | 37% | 40.05% |
| 30 | + | 364 | Hypothetical protein HMPREF9449_00933 |
| 0.00E+00 | 98% | 69% | 40.43 |
Abbreviations: aa = amino acid; % ID = % identity at amino acid level over the entire length of the protein; % G+C = Percentage guanine and cytosine content;
DUF = Domain of Unknown Function.
Figure 2Overview of SMG 6 fosmid insert and features of specific genes.
(A) Gene map of SMG 6 insert, displaying gene orientation and individual %G+C content indicated with a gradient colour bar. Gene numbers correspond to those in Table 2 and are drawn approximately to scale. (B) Focus on genes 25 (atfA) and 26 (brpA), showing the regions cloned for each construct. (C) Detailed view of putative ATG and TTG start codons of brpA, including upstream regions, as well as predicted promoter regions (highlighted in bold) and transcription factor binding site sequences (blue and orange boxes). (D) TMHMM prediction of seven transmembrane regions in BrpA.
Figure 3BrpA homologues identified when BLAST searched against Human Microbiome Project (HMP) datasets from 17 body sites at maximum e-value cut-off of (A) 1e−50 and (B) 1e−05.
Figure 4Growth of E. coli MKH13::pCI372 and E. coli MKH13 carrying a plasmid encoded copy of either brpA, brpA or brpAatfA in (A) LB broth or (B) LB+3% NaCl.
All of the genes confer a significant salt tolerance phenotype to MKH13 relative to cells with an empty plasmid vector. All values are the average of triplicate experiments and error bars are representative of the standard error of the mean (SEM).
Figure 5Pigmentation observed in cell pellets.
(A) Appearance of cell pellets grown in LB supplemented with β-carotene. From left to right: E. coli MKH13::pCI372, MKH13::pCI372-brpA, MKH13::pCI372-brpA and MKH13::pCI372-brpAatfA. (B) Appearance of cell pellets of clones grown in LB supplemented with β-carotene and Copy Control Induction solution (L-arabinose). From left to right: E. coli EPI300::pCC1FOS, SMG 1, SMG 6 and SMG 52. (C) Appearance of cell pellets grown in LB supplemented with β-carotene and L-arabinose. From left to right: E. coli EPI300::pBAD, EPI300::pBAD-brpA, EPI300::pBAD-brpA, and EPI300::pBAD-brpAatfA.
Figure 6EZTn5 transposon mutagenesis of SMG 6 was performed to identify mutants lacking pigmentation when grown in the presence of β-carotene.
(A) Clones positive for a transposon in this region of SMG 6 fosmid insert were identified by PCR, with amplicons of ∼3.3 kb indicative of an insertion event. (B) Approximate locations of transposon insertions in relation to brpA and neighbouring genes. (C) Appearance of cell pellets of SMG 6 and transposon insertion mutants (EZTn #24, #26, #34 and #38) following growth in the presence of β-carotene.
Figure 7Possible mechanism(s) of action of BrpA (A) Representation of the known reaction for the formation of retinal.
B-carotene is cleaved at its central 15,15′ bond by brp 15,15′- β-carotene monooxygenase to form two molecules of all-trans retinal (Vitamin A aldehyde). We propose that brpA may be regulated from two promoters, with translation being initiated from one of two potential start codons (ATG and TTG), depending on environmental conditions. While speculative, we illustrate some possibilities discussed in the text. (B) Pigmentation phenotype: regulation of brpA from promoter 1 (upstream of ATG start codon) under “normal” cellular conditions, or possibly by β-carotene, could result in (B1) BrpA adding an acyl group to β-carotene, allowing it to interact with phosphate head groups of lipids and anchoring it in the hydrophobic core of the lipid membrane or (B2) BrpA may cleave β-carotene to retinal and subsequently bind the derived retinal anchoring it in the cell membrane. (C) Stress response: regulation of brpA from promoter 2 (upstream of TTG start codon), may be initiated by environmental signals such as changes in external osmolarity, resulting in increased tolerance or resistance to environmental stress, such as increased NaCl concentrations by an as yet unknown mechanism. Alternative start codons, such as TTG, have been found in a number of stress response genes.